Newsroom
Sorted by: Latest
-
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Arcellx, Inc. (Nasdaq: ACLX). Under the terms of the transaction, Gilead acquired Arcellx for $115 per share in cash, plus one non‑transferable contingent value right (CVR) of $5 per share, representing a total implied equity value of approximately $7.8 billion at the time of closing. The acquisition builds on Kite, a Gilead Company, and...
-
NAIL-AID Accelerates National Growth Following Strong Portfolio Gains and Sell-Through of Newly Launched Cuticle Oil Jelly, Expands into High-Frequency Retail Channels
MIAMI--(BUSINESS WIRE)--NAIL-AID®, a 22-year leader in high-performance, accessible nail treatments made in the USA, announced strong national sales performance and continued expansion following the launch of its Cuticle Oil Jelly, a solid-state alternative to traditional liquid cuticle oils. Since launch, Cuticle Oil Jelly has delivered rapid sell-through across Walmart stores and sustained demand on Amazon, supported by double-digit turns and repeat purchase behavior. The performance reflects...
-
Venerable Announces New Legal and Compliance Executive Leadership
WEST CHESTER, Pa.--(BUSINESS WIRE)--Venerable is pleased to announce the promotion of Lee Barnard to Executive Vice President, Chief Legal Officer and Secretary, overseeing the organization’s Legal and Compliance teams. Since joining Venerable in 2020, Mr. Barnard has led the legal structuring and negotiation of complex M&A and reinsurance transactions, along with directly advising Venerable’s finance, risk, and investment management functions. In addition, since 2024, Mr. Barnard has manag...
-
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder
NEW YORK--(BUSINESS WIRE)--Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladde...
-
MicrosoftとPostel:データとAIを活用した革新的な新ソリューションで、イタリアの中小企業と顧客との関係を最適化
ローマ--(BUSINESS WIRE)--(ビジネスワイヤ) -- Microsoftと、 Poste Italiane Group傘下の企業であるPostelは、イタリア企業のデジタル化に向けた協業および締結済みの合意をさらに発展させ、Audiencerateをデータおよびダイレクト&デジタル・マーケティング分野のテクノロジー・パートナーとして迎えることを発表しました。 この合意に基づき、Postelの物理・デジタル両面のオムニチャンネル・コミュニケーション機能と、Audiencerateの データ・インテリジェンス機能およびMicrosoftのAIならびにクラウド・ソリューションを組み合わせた統合プラットフォームが提供されます。 このソリューションにより、中小企業は顧客との関係のライフサイクル全体を通じて自社データを活用・アクティベートし、オムニチャンネル・コミュニケーション・キャンペーンを自動化および統合管理できます。プラットフォームに組み込まれた市場分析機能により、企業は競合に関するインサイトやリアルタイムの業界トレンドにアクセスし、データを具体的な戦略的優位性へと...
-
Microsoft e Postel: Uma nova solução inovadora, baseada em dados e IA, para otimizar o relacionamento das PMEs italianas com seus clientes
ROMA--(BUSINESS WIRE)--A Microsoft e a Postel, da empresa Poste Italiane Group, anunciam uma evolução em sua colaboração e nos acordos firmados para a digitalização de empresas italianas, dando as boas-vindas à Audiencerate como parceira tecnológica na área de Dados e Marketing Direto e Digital. O acordo prevê a distribuição de uma plataforma integrada que combina os recursos de comunicação omnicanal física e digital da Postel com as funcionalidades de inteligência de dados da Audiencerate e as...
-
Microsoft i Postel: nowe innowacyjne rozwiązanie w zakresie danych wspomagane AI w celu optymalizacji relacji włoskich MŚP z klientami
RZYM--(BUSINESS WIRE)--Microsoft i Postel, spółka należąca do Poste Italiane Group, informują o rozszerzeniu współpracy i zawarciu umów w sprawie cyfryzacji włoskich przedsiębiorstw oraz dołączeniu Audiencerate jako partnera technologicznego w dziedzinie danych oraz marketingu bezpośredniego i cyfrowego. Umowa przewiduje dystrybucję zintegrowanej platformy łączącej wielokanałowe zdolności Postel w dziedzinie komunikacji fizycznej i cyfrowej z funkcjami Audiencerate w zakresie analityki danych o...
-
Microsoft与Postel合作推出创新的新数据和AI驱动解决方案,优化意大利中小企业与其客户的关系
罗马--(BUSINESS WIRE)--(美国商业资讯)-- Microsoft与 Poste Italiane Group下属公司Postel宣布深化双方合作以及所签订有关意大利企业数字化业务的协议,新增Audiencerate成为双方在数据以及直接与数字营销领域的技术合作伙伴。 该协议涉及发布一个综合性的平台,将Postel的全渠道实体及数字传播能力与Audiencerate的 数据情报功能以及Microsoft的人工智能(AI)和云解决方案相结合。 该解决方案可让中小企业在整个客户关系生命周期内利用并激活自己的数据,自动执行和安排全渠道传播活动。得益于该平台中内置的市场分析功能,企业将可以获得竞争洞察并实时了解行业趋势,将数据变为切实的战略优势。 Audiencerate是Microsoft AI Cloud Partner Program的全球合作伙伴,在自己的数据管理和激活基础设施中集成了Azure AI功能,让中小企业同样可以利用之前仅供大型企业使用的工具。 “通过本次合作,我们让数据成为意大利中小企业增长战略的核心,为他们提供之前专属于大型企业的AI和数字营销工具”,A...
-
Microsoft és Postel: Innovatív, új, adat- és mesterségesintelligencia-alapú megoldás az olasz kkv-k ügyfélkapcsolatainak optimalizálására
RÓMA--(BUSINESS WIRE)--A Microsoft és a Postel, a Poste Italiane Group vállalata bejelentette együttműködését, illetve az olasz vállalkozások digitalizációja érdekében aláírt megállapodásaik továbbvitelét, technológiai partnerként üdvözölve az Audiencerate-et, az adat- és direkt, valamint digitális marketing területén. A megállapodás egy integrált platform létrehozását célozza meg, amely a Postel többcsatornás („omnichannel") fizikai és digitális kommunikációs képességeit az Audiencerate adatel...
-
NRG Energy, Inc. Announces Early Results of Cash Tender Offer and Consent Solicitation
HOUSTON--(BUSINESS WIRE)--NRG Energy, Inc. (NYSE:NRG) announced today the early results of the previously announced offer to purchase for cash (the “Tender Offer”) for any and all of the outstanding 7.250% senior secured notes due 2032 (the “Notes”) issued by Lightning Power, LLC (“Lightning”), a wholly-owned subsidiary of NRG. In conjunction with the Tender Offer, Lightning also solicited consents (the “Consent Solicitation”) to adopt certain proposed amendments to the indenture governing the...